This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chatzaki, E. Articles by Gallagher, C. J. Search for Related Content PubMed PubMed Citation Articles by Chatzaki, E. Articles by Gallagher, C. J.

The Expression of Gonadotropin-releasing Hormone and its Receptor in Endometrial Cancer, and its Relevance as an Autocrine Growth Factor¹

Department of Medical Oncology, Colston Ward, King George V Building, St. Bartholomew's Hospital, West Smithfield, London EC1A 7BE [E. C., C. M. R. B., C. J. G.]; MRC Reproductive Biology Unit, 37 Chalmers Street, Edinburgh EH3 9EW [K. A. E., L. A.]; and Academic Department of Obstetrics and Gynaecology, Holland Wing, The Royal London Hospital, Whitechapel, London E1 1BB [J. G. G.], United Kingdom

The presence of a direct extra-pituitary action of gonadotropin-releasing hormone (GnRH) via specific receptors in endometrial cancer (EC) has been suggested as an explanation for the therapeutic effect of GnRH analogue (GnRHa) in recurrent disease. We have sought the expression of the GnRH peptide and functional GnRH receptor (GnRH-R) in human tissues and cell lines to investigate the possibility of an autocrine growth regulation mechanism. Using reverse transcription-PCR, differing GnRH mRNA transcripts were detected in two EC cell lines (Ishikawa and HEC-1A), a choriocarcinoma (JEG3) cell line, and tissues from endometrium and placenta. However, secretion of immunoreactive GnRH could be detected by RIA in only 1 of 10 EC tissues in primary culture, and in none of the cell lines. Low levels of GnRH-R mRNA expression were found in the same cells, which were only detectable by reverse transcription-PCR and Southern blotting of the PCR product. In radioligand binding assays using GnRHa goserelin, no pituitary-like, high-affinity GnRH binding sites could be found in either EC cell lines or tissues. Low affinity binding (K_d = 1.0–3.1 x 10^-7M) was detected in three of eight (37%) EC tissues. Furthermore, receptor signal transduction measurements carried out in these cells showed no increases in either total inositol phosphate, cyclic AMP production, or cytosolic CA²⁺ in response to either GnRH or GnRHa. Finally, no effect of either GnRH or GnRHa on the growth of EC cell lines was detected in vitro, under estrogen-free conditions, assessed by DNA content. Our data suggest that although there is a potential for autocrine activity for GnRH in EC as judged by the presence of mRNA for peptide and receptor, no functional receptor activity could be detected in vitro. Alternative mechanisms should be studied to explain the in vivo action of GnRHa.

¹ This study was supported by the Association for International Cancer Research Grant 95-42.

² To whom requests for reprints should be addressed.

Received 11/24/95. Accepted 3/ 4/96.

This article has been cited by other articles:

				S. L. Poon, B.-S. An, W.-K. So, G. L. Hammond, and P. C. K. Leung Temporal Recruitment of Transcription Factors at the 3',5'-Cyclic Adenosine 5'-Monophosphate-Response Element of the Human GnRH-II Promoter Endocrinology, October 1, 2008; 149(10): 5162 - 5171. [Abstract] [Full Text] [PDF]

				C. K. Cheng and P. C. K. Leung Molecular Biology of Gonadotropin-Releasing Hormone (GnRH)-I, GnRH-II, and Their Receptors in Humans Endocr. Rev., April 1, 2005; 26(2): 283 - 306. [Abstract] [Full Text] [PDF]

				W. Chen, S. Yoshida, N. Ohara, H. Matsuo, M. Morizane, and T. Maruo Gonadotropin-Releasing Hormone Antagonist Cetrorelix Down-Regulates Proliferating Cell Nuclear Antigen and Epidermal Growth Factor Expression and Up-Regulates Apoptosis in Association with Enhanced Poly(Adenosine 5'-Diphosphate-Ribose) Polymerase Expression in Cultured Human Leiomyoma Cells J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 884 - 892. [Abstract] [Full Text] [PDF]

				G S Harrison, M E Wierman, T M Nett, and L M Glode Gonadotropin-releasing hormone and its receptor in normal and malignant cells Endocr. Relat. Cancer, December 1, 2004; 11(4): 725 - 748. [Abstract] [Full Text] [PDF]

				S. Maudsley, L. Davidson, A. J. Pawson, R. Chan, R. L. de Maturana, and R. P. Millar Gonadotropin-Releasing Hormone (GnRH) Antagonists Promote Proapoptotic Signaling in Peripheral Reproductive Tumor Cells by Activating a G{alpha}i-Coupling State of the Type I GnRH Receptor Cancer Res., October 15, 2004; 64(20): 7533 - 7544. [Abstract] [Full Text] [PDF]

				S. Rama and A.J. Rao Embryo implantation and GnRH antagonists: The search for the human placental GnRH receptor Hum. Reprod., February 1, 2001; 16(2): 201 - 205. [Abstract] [Full Text] [PDF]

				F. Raga, E. M. Casañ, J. S. Kruessel, Y. Wen, H.-Y. Huang, C. Nezhat, and M. L. Polan Quantitative Gonadotropin-Releasing Hormone Gene Expression and Immunohistochemical Localization in Human Endometrium Throughout the Menstrual Cycle Biol Reprod, July 1, 1998; 59(3): 661 - 669. [Abstract] [Full Text]

				N. Sanno, L. Jin, X. Qian, R. Y. Osamura, B. W. Scheithauer, K. Kovacs, and R. V. Lloyd Gonadotropin-Releasing Hormone and Gonadotropin-Releasing Hormone Receptor Messenger Ribonucleic Acids Expression in Nontumorous and Neoplastic Pituitaries J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1974 - 1982. [Abstract] [Full Text] [PDF]